...
首页> 外文期刊>American Journal of Cancer Research >A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma
【24h】

A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma

机译:诺模图预测食管鳞状细胞癌患者各种炎症生物标志物的预后价值

获取原文
           

摘要

Background: Inflammation plays an important role in cancer progression and prognosis. However, the prognostic values of inflammatory biomarkers in esophageal cancer (EC) were not established. In the present study, therefore, we initially used a nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma (ESCC). Methods: A total of 326 ESCC patients were included in this retrospective study. Glasgow prognostic score (GPS), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and lymphocyte monocyte ratio (LMR) were analyzed in the current study. Kaplan-Meier method was used to calculate the cancer-specific survival (CSS). Cox regression analysis was also performed to evaluate the prognostic factors. A nomogram was established to predict the prognosis for CSS. Results: Patients were divided into 3 groups according to GPS (GPS 0, 1 and 2) and 2 groups according to NLR (≤3.45 and >3.45), PLR (≤166.5 and >166.5) and LMR (≤2.30 and >2.30). The 5-year CSS in patients with GPS 0, 1 and 2 were 49.2%, 26.8% and 11.9%, respectively (P<0.001). In addition, patients with NLR (>3.45), PLR (>166.5) and LMR (≤2.30) were significantly associated with decreased CSS, respectively (P<0.001). Multivariate analysis revealed that GPS (P<0.001), PLR (P=0.002) and LMR (P=0.002) were independent prognostic factors in patients with ESCC. In addition, a nomogram was established according to all significantly independent factors for CSS. The Harrell’s c-index for CSS prediction was 0.72. Conclusion: GPS, PLR and LMR were potential prognostic biomarkers in patients with ESCC. The nomogram based on CSS could be used as an accurately prognostic prediction for patients with ESCC.
机译:背景:炎症在癌症的进展和预后中起着重要作用。但是,尚未确定炎性生物标志物在食管癌(EC)中的预后价值。因此,在本研究中,我们最初使用诺模图预测食管鳞状细胞癌(ESCC)患者各种炎症生物标志物的预后价值。方法:本回顾性研究共纳入326例ESCC患者。在本研究中分析了格拉斯哥的预后评分(GPS),中性白细胞淋巴细胞比率(NLR),血小板淋巴细胞比率(PLR)和淋巴细胞单核细胞比率(LMR)。 Kaplan-Meier方法用于计算癌症特异性生存率(CSS)。还进行了Cox回归分析以评估预后因素。建立了诺模图以预测CSS的预后。结果:根据GPS将患者分为3组(GPS 0、1和2),根据NLR(≤3.45和> 3.45),PLR(≤166.5和> 166.5)和LMR(≤2.30和> 2.30)将患者分为2组。 。 GPS 0、1和2患者的5年CSS分别为49.2%,26.8%和11.9%(P <0.001)。此外,NLR(> 3.45),PLR(> 166.5)和LMR(≤2.30)的患者分别与CSS降低显着相关(P <0.001)。多因素分析表明,GPS(P <0.001),PLR(P = 0.002)和LMR(P = 0.002)是ESCC患者的独立预后因素。此外,根据所有明显独立的CSS因素建立了列线图。 Harrell的CSS预测c指数为0.72。结论:GPS,PLR和LMR是ESCC患者潜在的预后生物标志物。基于CSS的列线图可以作为ESCC患者的准确预后预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号